But how? Understanding the mode of action of a probiotic in the management of IBS symptoms.
Professor Eamonn Quigley currently resides in Houston Methodist Hospital as head of its Gastroenterology and Hepatology division. He has previously been president of both the American College of Gastroenterology and the World Gastroenterology Organisation, and is internationally known for his research on gastrointestinal motility disorders, IBS and the gut microbiome.
Learning Objectives:
1. Understand the importance of the gut microbiome, and its significance in the management of the symptoms of IBS2. Understand the specific modes of action of the Bifidobacterium longum 35624® probiotic strain3. Understand the relationships between the modes of action of Bifidobacterium longum 35624® and clinical outcomes of individuals with symptoms of IBS after receiving this probiotic strainRecommended for you…
CPD e-learning
0.5 CPD learning hour
CPD e-learning
1 CPD learning hour
Webinar on Demand
0.5 CPD learning hour
Clinical Summary
~5 minute read